The hearing marks a significant milestone in the ongoing effort to reschedule marijuana from its current status as a Schedule I substance to a less restrictive Schedule III.
Rescheduling marijuana would make cannabis eligible for certain benefits not currently available to businesses, including federal tax deductions that have long been a barrier.
While rescheduling would not eliminate existing federal prohibitions on cannabis use, it could facilitate expanded research into marijuana's medical uses.
The process has already drawn considerable attention and sparked widespread debate across the public and legal sectors, highlighting the challenges and skepticism surrounding marijuana rescheduling.
#marijuana-rescheduling #dea-hearing #controlled-substances-act #legalization-debate #cannabis-industry
Collection
[
|
...
]